Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...
In an international trial of 713 adults in nine countries including the U.S. called SUMMIT, participants with heart failure ...
Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback